Corpus Intelligence IC Memo — MERIT HEALTH WOMANS HOSPITAL 2026-04-26 03:44 UTC
IC Memo — MERIT HEALTH WOMANS HOSPITAL
Investment Committee Memorandum | MS | 34 beds | Grade D | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERIT HEALTH WOMANS HOSPITAL

CCN 250136 | RANKIN, MS | 34 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MERIT HEALTH WOMANS HOSPITAL is a 34-bed safety-net/medicaid heavy in RANKIN, MS with $29.6M in net patient revenue and a 3.5% operating margin. The hospital serves a payer mix of 0.3% Medicare, 25.8% Medicaid, and 73.9% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.5% to 10.9% (+736bps).

Net Revenue HCRIS$29.6M
Current EBITDA COMPUTED$1.0M
Operating Margin COMPUTED3.5%
Occupancy HCRIS35.6%
Revenue / Bed COMPUTED$870K
Net-to-Gross HCRIS11.4%
Distress Probability ML53.9%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
68
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 3.5% places it above the state median. Among 68 size-comparable peers (17-68 beds), the median margin is -14.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (17-68), prioritizing same-state peers. 68 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERIT HEALTH WOMANS HOSPITAL (Target)MS34$29.6M3.5%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
METHODIST H/C OLIVE BRANCH HOSMS65$75.4M-25.6%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
CLAY COUNTY MEDICAL CORPORATIOMS49$45.4M0.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$621K+210bp18mo
Cost to Collect4.5%2.5%$591K+200bp12mo
Denial Rate Reduction12.0%6.5%$585K+198bp12mo
A/R Days Reduction5200.0%3800.0%$360K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$621K
Cost to Collect
$591K
Denial Rate Reduction
$585K
A/R Days Reduction
$360K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$1.0M
+ RCM Uplift+$2.2M
Pro Forma EBITDA$3.2M
Current Margin3.5%
Pro Forma Margin10.9%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.6M$28.7M17.79x77.8%
Base (11x exit)10.0x11.0x$1.6M$32.1M19.90x81.9%
Bull Case9.0x11.0x$1.5M$39.8M27.42x93.9%
Bull (12x exit)9.0x12.0x$1.5M$43.8M30.21x97.7%
Bear Case11.0x10.0x$1.8M$17.3M9.74x57.7%
Bear (11x exit)11.0x11.0x$1.8M$19.6M11.04x61.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (25.8%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 53.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 68 hospitals with 17-68 beds
  • Same-state prioritization (n=69)
  • Comp margins: P25=-25.5% / P50=-14.4% / P75=-5.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.